Des pathologies telles que la myopathie et certains types de cancer, peuvent être causées par une mauvaise formation de l’enveloppe nucléaire (EN), processus se produisant lors de chaque division cellulaire mais aussi lors de la formation du pronoyau mâle. Un modèle in vitro, dérivé de gamètes d’oursins, a été utilisé afin d’étudier les différentes étapes de formation de l’EN et a permis de révéler plusieurs informations essentielles. Un des points critiques est que des membranes fortement enrichies en phosphoinositides polyphosphorylés (PPIs) sont essentielles à la formation de l’EN, notamment lors des étapes de fusion membranaire. Ces membranes proviennent du cytoplasme de l’ovocyte fécondé (MV1) et des noyaux de spermatozoïdes (NERs). Nous avons construit des modèles membranaires mimant les compositions lipidiques de ces membranes, puis étudié leur structure, leur dynamique ainsi que leur morphologie par spectroscopie de RMN des solides et microscopie électronique. Nous avons montré que les PPIs induisent une courbure membranaire positive, conduisant à la formation de petites vésicules ou de micelles allongées. Plus important encore, dans le modèle « MV1», les membranes sont très fluides. Le modèle « NERs » est constitué de membranes globalement ordonnées, semblables aux phases dites « liquides ordonnées » avec une modulation apportée par la PPIs. Nous avons également construit un modèle membranaire minant la composition lipidique des vésicules MV2, membranes non-enrichies en PPIs mais représentant 90 % des vésicules participant à la formation de l’EN. Ce modèle membranaire présente une dynamique intermédiaire à celle observée pour les modèles MV1 et NERs. Ces propriétés nouvelles ont permis de proposer un mécanisme décrivant le rôle des PPIs lors de la fusion membranaire conduisant à la formation de l’enveloppe nucléaire. / Diseases, such as myopathies and some types of cancer, can be caused by abnormal nuclear envelope (NE) assembly, a process that takes place at each cell division and during male pronuclear formation. A cell-free assay from sea urchin gametes, that mimics the in vivo male pronucleus formation, has been used to dissect the various stages of NE assembly. This in vitro assay has revealed several novel features. One of the critical aspects is that membranes highly enriched in polyphosphorylated phosphoinositides (PPIs), are essential for NE formation, especially during the stage of membrane fusion. Theses membranes are extracted from the cytoplasm of the fertilised oocyte (MV1) and sperm nuclei (NERs). We made model membranes with similar lipid composition to MV1 and NERs and studied their structure, dynamics and morphologies by solid-state NMR spectroscopy and electron microscopy. We show that PPIs have a positive membrane curvature, inducing small vesicles and elongated micelles. More importantly, we illustrate that “MV1-like” membranes are very fluid. “NERs-like” membranes are globally ordered and belong to the family of liquid ordered phases. We also evidenced that PPIs can counterbalance in part the ordering effect of cholesterol. Moreover we made model membranes with similar lipid composition to MV2, non-enriched in PPIs membranes which constitute 90% of the vesicles forming the NE. This model membrane shows an in-between dynamics compared to MV1 and NERs. We therefore propose a mechanism describing the role of PPIs during membrane fusion leading to nuclear membrane assembly.

Les protéines ERMs (Ezrine, radixine et moésine) jouent un rôle central in cellulo, dans de nombreux processus cellulaires tels que les infections, la migration et la division cellulaire. Parmi celles-ci, la moésine est plus particulièrement impliquée dans la formation de la synapse immunologique, l’infection virale et bactérienne, et les métastases cancéreuses. D’un point de vue structural, les ERM peuvent être en conformation inactive (replies sur elles-mêmes) ou actives (ouvertes), ce qui permet leur interaction a la fois avec les constituants du cytosquelette (actine et tubuline) via leur domaine C-terminal et la membrane plasmique via leur domaine FERM. La liaison a la membrane plasmique se fait principalement et spécifiquement via un lipide de la famille des phosphoinositides, le phosphatidyl 4,5 bisphosphate (PIP2). De plus, les protéines peuvent être phosphorylées, ce qui contribue à leur ouverture structurale. Cependant, le rôle de la phosphorylation sur les interactions ERM/membrane et ERM/cytosquelette, bien que beaucoup étudié in cellulo, est peu compris au niveau moléculaire.Le but de cette thèse est précisément d’étudier, au niveau moléculaire et à l’aide de systèmes biomimétiques, les interactions entre des protéines recombinantes et des membranes biomimétiques contenant du PIP2. Pour cela, nous avons mis au point des membranes lipidiques sous forme de vésicules unilamellaires (petites ou larges) et de bicouches lipidiques supportées, qui permettent de caractériser les interactions entre protéines et membranes par des techniques biophysiques complémentaires, notamment la cosédimentation quantitative, la microscopie et spectroscopie de fluorescence, et la microbalance à cristal de quartz. Dans une première partie, nous avons étudié le rôle de la double phosphorylation de la moésine (réalisée par mutation sur site spécifique) sur les interactions moésine/membrane biomimétique, en comparaison de la protéine sauvage, les protéines recombinantes et les mutants ayant été produites et purifiées au laboratoire.Nos résultats mettent en évidence une interaction spécifique et coopérative pour le double mutant phosphomimétique alors que cette interaction est simple dans le cas de la protéine sauvage. Dans une seconde partie, nous avons employé les bicouches lipidiques supportées contenant le PIP2 pour étudier les mécanismes molécules d’adsorption de la protéine virale Gag et de ses mutants. Les méthodologies développées dans ce travail de thèse ouvrent des perspectives en biophysique moléculaires car elles sont facilement transposables à l’étude d’autres protéines sur des membranes lipidiques modèles contenant des phosphoinositides.Mots clés: Ezrine-Radixine-Moésine, phosphoinositides, PIP2, interactions protéine-lipide, membrane lipidique biomimétique, protéine virale Gag, cytosquelette. / ERM (ezrin, radixin, moesin) proteins play a central role in cellulo in a large number of physiological and pathological processes, including cell infection, migration and cell division. Among the ERMs, moesin is particularly involved in the formation of the immunological synapse, viral and bacterial infection, and cancer metastasis. From a structural point of view, ERMs can be in inactive (closed) conformation or active (open), which enable them to interact on one side with the cytoskeleton (actin and tubulin) via their C-terminal domain and on the other side with the plasma membrane via their FERM domain. Binding to the plasma membrane is mediated via a specific lipid of the phosphoinositide family, the phosphatidylinositol(4,5)bisphosphate (PIP2). In addition, ERM can be phosphorylated, which contribute to their structural opening. To date, the role of the phosphorylation in ERM/membrane and ERM/cytoskeleton interactions, although widely studied in cellulo, remains poorly understood at the molecular level.The aim of this PhD thesis is precisely to study, at the molecular level and using biomimetic systems, interactions between recombinant proteins and biomimetic membranes containing PIP2. To this end, we have engineered lipid membranes in the form of large and small unilamellar vesicles and supported lipid bilayers. These biomimetic membranes are used to characterize interactions between proteins and membranes by complementary biophysical techniques, notably quantitative cosedimentation, fluorescence microscopy and spectroscopy, and quartz crystal microbalance with dissipation monitoring. In a first part, we studied the role of double phosphorylation on moesin, achieved via a site-specific mutation on threonine residues, on moesin/biomimetic membrane interactions, in comparison to the wild type protein. The recombinant proteins and mutants were produced in our laboratory.Our results show that there is a specific and cooperative interaction for the double phosphomimetic mutant while interactions is 1:1 in the case of the wild type protein. In a second part, we used supported lipid bilayers containing PIP2 to study the molecular adsorption mechanism of the viral protein Gag and of its mutants. The methodologies that were developed in this work open perspectives in molecular biophysics since they are easily adaptable to other proteins on model lipid membranes containing phosphoinositidesKeywords: Ezrin-Radixin-Moesin, phosphoinositides, PIP2, protein/lipid interactions, biomimetic lipid membrane, Gag viral protein, cytoskeleton.

The influenza A virus non-structural (NS1) protein is multifunctional, and during virus-infection NS1 interacts with several factors in order to manipulate host-cell processes. This study reports that NS1 binds directly to p85β, a regulatory subunit of phosphoinositide 3-kinase (PI3K), but not to the related p85α. Expression of NS1 was sufficient to activate PI3K and cause the phosphorylation of a downstream mediator of PI3K signalling, Akt. However, in virus-infected MDCK cells, the kinetics of Akt phosphorylation did not correlate with NS1 expression, and suggested that negative regulation of this signalling pathway occurs subsequent to ~8h post-infection. Mapping studies showed that the NS1:p85β interaction is primarily mediated by the NS1 C-terminal domain and the p85β inter-SH2 (Src homology 2) domain. Additionally, the highly conserved tyrosine at residue 89 (Y89) of NS1 was found to be important for binding and activating PI3K in a phosphorylation-independent manner. The inter-SH2 domain of p85β is a coiled-coil structure that acts as a scaffold for the p110 catalytic subunit of PI3K. As NS1 does not displace p110 from the inter-SH2 domain, a model is proposed whereby NS1 forms an active heterotrimeric complex with PI3K, and disrupts the ability of p85β to control p110 function. Biological studies revealed that a mutant influenza A virus (Udorn/72) expressing NS1 with phenylalanine substituted for tyrosine-89 (Y89F) exhibited a small-plaque phenotype, and grew more slowly in MDCK cells than wild-type virus. Unexpectedly, another mutant influenza A virus strain (WSN/33) expressing NS1-Y89F was not attenuated in MDCK cells, yet appeared to be less pathogenic than wild-type in vivo. Overall, these data indicate a role for NS1-mediated PI3K activation in efficient influenza A virus replication. The potential application of this work to the design of novel anti-influenza drugs and vaccine production is discussed.

The phosphatidylinositol polyphosphates play a fundamental role in intracellular signalling. Of particular importance is phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P₃], which acts by recruiting effector proteins to the cell membrane. PtdIns(3,4,5)P₃ interacts with its protein targets through selective binding domains that include the pleckstrin homology (PH) domain. The PH-domain-containing kinase, protein kinase B (PKB/Akt), which interacts with PtdIns(3,4,5)P₃, is upregulated in ~15 human malignancies. Significantly, inhibition of the PtdIns(3,4,5)P₃-PKB interaction has proved viable as a point of therapeutic intervention. There is currently a lack of small molecule probes that selectively interact with a given PH domain. Consequently, it is impossible to dissect the cellular function of PH-domain-containing proteins at a molecular level. To address this problem, we have designed and synthesised a number of derivatives of the PtdIns(3,4,5)P₃ inositol head-group – Ins(1,3,4,5)P₄. Replacement of the 5-position phosphate with a range of phosphate bioisosteres afforded compounds that displayed no binding affinity for the PH-domain of general receptor for phosphoinositides 1 (GRP1). However, it was shown that the 5-position sulfamate analogue displayed selectivity for the PH-domain of PKB. The methylphosphate biosiostere at the 1-position displayed binding for both the GRP1 PH-domain as well as the PKB PH-domain. These results demonstrate that subtle modification of the Ins(1,3,4,5)P₄ structure allows the synthesis of compounds that interact selectively with a given PH domain. We will now use these results for the synthesis of a second generation of compounds with improved PH-domain affinity and selectivity.

Regulation of the actin cytoskeleton is key to cellular function and underlies processes including cell migration, mitosis and endocytosis. Motile cells send out dynamic actin protrusions that enable them to sense and interact with their environment, as well as generating physical forces. Linking of the actin cytoskeleton to the cell membrane is essential for the formation of these protrusions. The proteins that are thought to fulfil such a role have a membrane interacting domain (such as the PH domain in lamellipodin, or I-BAR protein in IRSp53) and a domain which interacts with actin regulatory proteins (such as the SH3 domain of IRSp53, which binds Ena and VASP). I investigated the contribution of the F-BAR protein Toca-1 in linking actin polymerisation to membranes, by characterising a new protein-protein interaction and the interaction of Toca-1 with giant unilamellar vesicles. FBP17, a homologue of Toca-1, can oligomerise to form 2D flat lattices and 3D tubules on membranes. Proteins of the Toca-1 family have previously been implicated in actin polymerisation in cell-free systems and during endocytosis. However, there is emerging evidence that Toca-1 family proteins could also be involved in the formation of outward facing protrusions, lamellipodia and filopodia. In an in vitro system that recapitulates the formation of filopodia-like structures (FLS) on supported lipid bilayers, Toca-1 is recruited early, suggesting a Toca-1 scaffolding mechanism could precede the recruitment of other actin regulators. One prediction of this model is that Toca-1 would bind proteins previously implicated in filopodia formation, such as formins. I found that extracts depleted of Toca-1 binding partners no longer forms filopodia-like structures and subsequently optimised pull-down assays to identify Toca-1 binding partners by mass-spectrometry. I identified four formins, Diaph1, Diaph3, FHOD1 and INF2, and as well as the actin elongation factors and filopodia proteins, Ena and VASP. I further characterised these interactions and found that Toca-1 binds Ena and VASP via its SH3 domain. The interaction is direct and is strongly reduced if the proline-rich region in Ena is deleted. VASP was still able to bind without its proline rich region, suggesting there could be additional binding sites. I discovered that the binding of Ena and VASP was dependent on the clustering state of Toca-1, whilst the binding of the previously identified Toca-1 binding partner N-WASP was not. This further supports the importance of Toca-1 oligomerisation in actin polymerisation. I tested these interactions in the FLS system and found that increasing Toca-1 concentration leads to increased recruitment of N-WASP, as well as the novel binding partner Ena to the structures, whereas an increase in VASP was not observed. SH3-domain mediated interactions are required for Toca-1 recruitment to FLS, suggesting that its membrane and protein binding activities act cooperatively. I showed that unlike N-WASP, which promotes the formation of branched actin, Ena and VASP are not required for actin polymerisation on supported lipid bilayers, suggesting that they are redundant with other factors in the elongation step of FLS formation. Ena and VASP are known to be important for the formation of neuronal filopodia and so I began to further test the role of these interactions in a cellular context using a neuronal cell culture system. As well as recruiting protein binding partners, F-BAR family proteins are implicated in stabilising lipid microdomains and can induce the clustering of phosphoinositides. I investigated the role of Toca-1 in actin polymerisation on PI(4,5)P2-rich giant unilamellar vesicles (GUVs). Actin-rich tails formed on the GUVs only when excess Toca-1 was supplemented into the extracts, and I propose that this is due to lipid organisation by Toca-1. In summary, my work suggests a model in which Toca-1 clusters, stabilises the membrane lipids and recruits regulators of actin polymerisation, such as Ena. This mechanism could be used to link actin polymerisation to the membrane in cellular protrusions, such as filopodia.

No description available.

<p>The spectrin-ankyrin network assembles diverse plasma membrane domains including axon initial segments and nodes of Ranvier, cardiomyocyte T-tubules and intercalated discs, epithelial lateral membranes, costameres and photoreceptor inner and outer segments. However the mechanism that targets the spectrin-ankyrin network to those plasma membrane domains is unknown. This thesis identifies two lipid inputs from protein palmitoylation and phosphoinositides that together control the precise localization of the spectrin-ankyrin network. In Chapter 2, we identify a linker peptide encoded by a single divergent exon that distinguishes the subcellular localization of ankyrin-B and -G by selectively suppressing protein binding through autoinhibition. In Chapter 3, we demonstrate that ankyrin-G is S-palmitoylated at a conserved C70 residue which is required to assemble epithelial lateral membranes and neuronal axon initial segments. We continue to interrogate how palmitoylation regulates ankyrin-G activities in Chapter 4, and identify DHHC5 and DHHC8 as the palmitoyltransferases in MDCK cells. We showed that palmitoylated ankyrin-G, in concert with phosphoinositide lipids, determines the polarized localization of beta II spectrin though a coincidence detection mechanism. This palmitoyltransferases/ ankyrin-G/beta II spectrin pathway determines the cell height of columnar epithelial cells. In Chapter 5, we elucidated the molecular mechanism through which the spectrin-ankyrin network assembles epithelial lateral membranes. We demonstrated that ankyrin-G and beta II spectrin function by opposing clathrin-mediated endocytosis to build the lateral membrane in MDCK cells. Together, this thesis dissects the mechanisms of how the spectrin-ankyrin network achieves precise membrane targeting and how it assembles lateral membranes to determine the morphogenesis of columnar epithelial cells, and provides the first molecular insight to understand how cells control the assembly of diverse plasma membrane domains.</p> / Dissertation

Thesis (Ph. D.)--West Virginia University, 2007. / Title from document title page. Document formatted into pages; contains viii, 306 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references.

La liaison de l’insuline à son récepteur permet le recrutement de protéines adaptatrices, ce qui conduit notamment à l’activation de la voie mitogénique des MAPK et des voies impliquées dans le métabolisme du glucose. Deux voies complémentaires contribuent au recrutement du transporteur de glucose, GLUT4, à la membrane ;la voie de la PI3-kinase qui implique la formation du messager secondaire PtdIns(3,4,5)P3 conduisant à l’activation de la PKB et la voie de la petite protéine G, TC10, qui implique les protéines APS, CAP et c-Cbl. <p><p>La phosphatidylinositol 5-phosphatase 2 (SHIP2) contrôle négativement la voie des MAPK par interaction avec des acteurs de la cascade et la voie de la PI3-kinase en hydrolysant le PtIns(3,4,5)P3 en PtIns(3,4)P2. De plus, il a été montré dans notre laboratoire que SHIP2 peut interagir directement avec la protéine CAP ainsi que co-immunoprécipiter avec le récepteur de l’insuline et c-Cbl, participant ainsi à un complexe multiprotéique formé des protéines CAP et c-Cbl et du récepteur. Au cours de ce travail, nous avons tenté de mieux comprendre l’implication moléculaire de SHIP2 dans la cascade TC10. Comme APS est la première protéine de la cascade à être recrutée au récepteur suite à une stimulation par l’insuline et qu’elle peut interagir directement avec le récepteur et les protéines CAP et c-Cbl, nous avons étudié dans un premier temps le lien potentiel entre APS et SHIP2.<p><p>Nous avons montré que SHIP2 interagit de manière directe avec la protéine adaptatrice APS tant dans un système de sur-expression (CHO-IR) que dans un système endogène (3T3-L1). Bien qu’une stimulation par l’insuline ne semble pas modifier cette interaction, elle induit néanmoins le recrutement d’une fraction des protéines APS et SHIP2 du cytoplasme vers la membrane plasmique. L’étude des domaines d’interaction a montré que la région centrale de SHIP2 qui comprend le domaine catalytique est nécessaire pour cette association. <p><p>Nous avons ensuite montré que cette association entre APS et SHIP2 peut moduler certaines de leurs propriétés biochimiques. D’une part, bien que la sur-expression de SHIP2 n’influence pas le recrutement d’APS au récepteur, SHIP2 diminue, indépendamment de son activité enzymatique, la phosphorylation sur tyrosine d’APS induite par l’insuline et l’interaction entre APS et c-Cbl, qui sont deux étapes cruciales dans la cascade TC10. Ainsi, SHIP2 pourrait non seulement influencer la cascade de l’insuline par son activité enzymatique, mais également par interaction avec des acteurs de la cascade. D’autre part, APS augmente l’activité 5-phosphatase de SHIP2 dans un test in vitro. Elle pourrait ainsi, outre son rôle positif dans la cascade, participer au rétrocontrôle négatif de la voie de signalisation à l’insuline. Finalement, nous avons déterminé comment ces deux protéines influencent les cascades de l’insuline. Alors qu’APS n’influence pas l’activation de la PKB, ni le taux de PtdIns(3,4,5)P3, la sur-expression d’APS et de SHIP2 induit une inhibition plus forte de l’activation de la PKB comparée à celle provoquée par SHIP2 seul. De plus, une sur-expression de SHIP2 abolit l’augmentation induite par APS de la phosphorylation des MAPK. Cette activation des MAPK par APS semble dépendre de sa liaison au récepteur car les domaines PH et essentiellement SH2 sont indispensables pour cet effet positif.<p><p>En conclusion, nous avons mis en évidence l’existence d’une association entre APS et SHIP2. Cette interaction modifie certaines de leurs propriétés biochimiques et fournit un nouveau mécanisme d’action pour ces protéines dans le contrôle négatif de la voie de signalisation à l’insuline. <p><p> / Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished

Thesis (MSc (Physiological Sciences))--Stellenbosch University, 2008. / Cells are equipped with an array of adaptive mechanisms to contest the undesirable effects of ischemia and the associated hypoxia. Indeed, many studies have suggested that there is an increase in the PI3K/Akt pathway activation during hypoxia and ischemia. Damaged muscle can be regenerated by recruiting myogenic satellite cells which undergo differentiation and ultimately lead to the regeneration of myofibres. The C2C12 murine myogenic cell line is popular for studying myogenesis in vitro, and has been used in many studies of ischemic microenvironments. PI3K/Akt pathway activity is increased during C2C12 myogenesis and this is known to produce an apoptosis resistant phenotype. In this study, we provide evidence that high basal levels of PI3K activity exist in C2C12 myotubes on day ten post-differentiation. Ischemia is characterized by depleted oxygen and other vital nutrients, and ischemic cell death is believed to be associated with an increasingly harsh environment where pH levels decrease and potassium levels increase. By employing a model that mimics these changes in skeletal muscle culture, we show that both acute simulated ischemia and acute hypoxia cause decreases in endogenous levels of the p85 and p110 subunits of PI3K and a consequent reduction in PI3K activity. Supplementing skeletal muscle cultures with inhibitors of the PI3K pathway provides evidence that the protective effect of PI3K/Akt is subsequently lost in these conditions. Using Western blot analysis, a PI3K ELISA assay as well as known inhibitors of the PI3K pathway in conjunction with the MTT assay we are able to demonstrate that the activation of downstream effectors of PI3K, including Akt, are concurrently decreased during acute simulated ischemia and acute hypoxia in a manner that is independent of PDK-1 and PTEN and that the decreases in the PI3K/Akt pathway activity produce a knock-on effect to the downstream signalling of transcription factors, such as Fox01 and Fox04, in our model. We proceed to provide compelling evidence that the apoptotic resistance of C2C12s is at least partially lost due to these decreases in PI3K/Akt pathway activity, by showing increased caspase-3 and PARP cleavage. Then, using vital staining techniques and a DNA fragmentation assay, we demonstrate increased cell membrane impairment, cell death and apoptosis after three hours of simulated ischemia and hypoxia in cultured C2C12 myotubes. In addition to the main findings, we produce evidence of decreased flux through the mTOR pathway, by showing decreased Akt-dependant phosphorylation at the level of TSC2 and mTOR during simulated ischemia and hypoxia. Finally, we present preliminary findings indicating increased levels of HIF1α and REDD-1, representing a possible oxygen sensing mechanism in our model. Therefore, we show that there is in fact a rapid decrease in PI3K/Akt activity during severe, acute simulated ischemia and hypoxia in C2C12 myotubes on day ten post-differentiation, and this causes a concomitant down regulation in cell survival pathways and increased activity of cell death machinery. Thereafter, we propose a possible mechanism of action and provide a platform for future studies.